JP2004504025A - 大腸菌における、コマモナスのシクロペンタノン１，２−モノオキシゲナーゼをコードする遺伝子 - Google Patents
大腸菌における、コマモナスのシクロペンタノン１，２−モノオキシゲナーゼをコードする遺伝子 Download PDFInfo
- Publication number
- JP2004504025A JP2004504025A JP2002512345A JP2002512345A JP2004504025A JP 2004504025 A JP2004504025 A JP 2004504025A JP 2002512345 A JP2002512345 A JP 2002512345A JP 2002512345 A JP2002512345 A JP 2002512345A JP 2004504025 A JP2004504025 A JP 2004504025A
- Authority
- JP
- Japan
- Prior art keywords
- cpmo
- cyclopentanone
- monooxygenase
- dna
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010036861 Cyclopentanone monooxygenase Proteins 0.000 title claims abstract description 74
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 14
- 108090000623 proteins and genes Proteins 0.000 title abstract description 42
- 241000589519 Comamonas Species 0.000 title abstract description 5
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- 108020004414 DNA Proteins 0.000 claims description 41
- 210000004027 cell Anatomy 0.000 claims description 24
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 claims description 20
- 239000013598 vector Substances 0.000 claims description 19
- 150000007523 nucleic acids Chemical group 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 15
- 239000013612 plasmid Substances 0.000 claims description 13
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 11
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 6
- 241001478312 Comamonas sp. Species 0.000 claims description 5
- 230000002068 genetic effect Effects 0.000 claims description 5
- 238000009396 hybridization Methods 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004511 Recombinant DNA Proteins 0.000 claims description 2
- 108020005202 Viral DNA Proteins 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 230000007850 degeneration Effects 0.000 claims 1
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 17
- 101100497181 Comamonas sp. (strain NCIMB 9872) cpnB gene Proteins 0.000 abstract description 12
- 150000001413 amino acids Chemical class 0.000 abstract description 9
- 239000012634 fragment Substances 0.000 abstract description 9
- 241000589516 Pseudomonas Species 0.000 abstract description 5
- 241000588625 Acinetobacter sp. Species 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 2
- 101710136644 Cyclohexanone 1,2-monooxygenase Proteins 0.000 abstract 2
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 101150019610 cpnB gene Proteins 0.000 description 6
- 108010058646 cyclohexanone oxygenase Proteins 0.000 description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 101710197852 Baeyer-Villiger monooxygenase Proteins 0.000 description 4
- 101710137307 FAD-containing monooxygenase EthA Proteins 0.000 description 4
- 241000589774 Pseudomonas sp. Species 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241001646716 Escherichia coli K-12 Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 2
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 2
- 102100024407 Jouberin Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000187693 Rhodococcus rhodochrous Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 101150076343 cpnA gene Proteins 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- PHOJOSOUIAQEDH-UHFFFAOYSA-N 5-hydroxypentanoic acid Chemical compound OCCCCC(O)=O PHOJOSOUIAQEDH-UHFFFAOYSA-N 0.000 description 1
- VBKPPDYGFUZOAJ-UHFFFAOYSA-N 5-oxopentanoic acid Chemical compound OC(=O)CCCC=O VBKPPDYGFUZOAJ-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 108030006984 Cyclopentanol dehydrogenases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000702374 Enterobacteria phage fd Species 0.000 description 1
- 102100031938 Eppin Human genes 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 101710096620 Nitrogen regulatory protein Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101710155159 Phosphotransferase enzyme IIA component Proteins 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102000009105 Short Chain Dehydrogenase-Reductases Human genes 0.000 description 1
- 108010048287 Short Chain Dehydrogenase-Reductases Proteins 0.000 description 1
- 101100038645 Streptomyces griseus rppA gene Proteins 0.000 description 1
- DJPZSBANTAQNFN-UHFFFAOYSA-N Testosterone acetate Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(OC(=O)C)C1(C)CC2 DJPZSBANTAQNFN-UHFFFAOYSA-N 0.000 description 1
- 101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 108010027388 phenol 2-monooxygenase Proteins 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- DJPZSBANTAQNFN-PXQJOHHUSA-N testosterone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 DJPZSBANTAQNFN-PXQJOHHUSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
- C12Y114/13016—Cyclopentanone monooxygenase (1.14.13.16)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21884200P | 2000-07-18 | 2000-07-18 | |
| PCT/CA2001/001032 WO2002006452A2 (en) | 2000-07-18 | 2001-07-13 | Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004504025A true JP2004504025A (ja) | 2004-02-12 |
| JP2004504025A5 JP2004504025A5 (enExample) | 2005-06-09 |
Family
ID=22816718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002512345A Pending JP2004504025A (ja) | 2000-07-18 | 2001-07-13 | 大腸菌における、コマモナスのシクロペンタノン１，２−モノオキシゲナーゼをコードする遺伝子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7214520B2 (enExample) |
| EP (1) | EP1303614A2 (enExample) |
| JP (1) | JP2004504025A (enExample) |
| AU (1) | AU2001276210A1 (enExample) |
| CA (1) | CA2418155A1 (enExample) |
| WO (1) | WO2002006452A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2418155A1 (en) * | 2000-07-18 | 2002-01-24 | National Research Council Of Canada | Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| FR2848564B1 (fr) * | 2002-12-13 | 2006-12-01 | Inst Rech Developpement Ird | Souches bacteriennes du genre exiguobacterium, procede de culture et applications |
| WO2004074327A1 (ja) * | 2003-02-19 | 2004-09-02 | Kansai Paint Co., Ltd. | 水性樹脂分散体の製造方法 |
| EP2510089B1 (en) | 2009-12-08 | 2015-10-21 | Codexis, Inc. | Synthesis of prazole compounds |
| HUE037616T2 (hu) | 2010-12-08 | 2018-09-28 | Codexis Inc | Biokatalizátorok és eljárások armodafinil szintéziséhez |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2520753B1 (fr) | 1982-02-01 | 1986-01-31 | Transgene Sa | Nouveaux vecteurs d'expression de la catechol 2,3-oxygenase, enzymes obtenues et leurs applications |
| JPH0648984B2 (ja) | 1986-03-28 | 1994-06-29 | 出光興産株式会社 | 遺伝子 |
| JPH0728747B2 (ja) | 1986-05-28 | 1995-04-05 | 出光興産株式会社 | ベンゼンオキシゲナーゼ遺伝子および該遺伝子で形質転換された原核生物細胞 |
| JPS6344888A (ja) | 1986-08-12 | 1988-02-25 | Agency Of Ind Science & Technol | チトクロムｐ−４５０とｎａｄｐｈ−チトクロムｐ−４５０還元酵素のキメラ融合酸化酵素 |
| DE3629890A1 (de) | 1986-08-29 | 1988-03-10 | Schering Ag | Mikroorganismen und plasmide fuer die 2,4-dichlorphenoxyessigsaeure (2,4-d)-monooxigenase - bildung und verfahren zur herstellung dieser plasmide und staemme |
| JPS6474983A (en) | 1987-09-14 | 1989-03-20 | Light Oil Utilization Res Ass | Novel oxygenase for cyclohexanone and its preparation |
| US5079166A (en) | 1988-04-05 | 1992-01-07 | Amgen Inc. | Microbial degradation of trichloroethylene |
| US5605823A (en) | 1988-04-05 | 1997-02-25 | Amgen Inc. | Bioconversions catalysed by the toluene monooxygenase of Pseudomonas mendocinaKR-1 |
| US5171684A (en) | 1988-04-05 | 1992-12-15 | Amgen Inc. | Bioconversions catalyzed by the toluene monooxygenase of Pseudomanas mendocina KR-1 |
| US5017495A (en) | 1988-04-05 | 1991-05-21 | Amgen Inc. | Plasmid encoding the Pseudomonas mendocina toluene monooxygenase gene |
| JP2792052B2 (ja) | 1988-10-28 | 1998-08-27 | 三菱化学株式会社 | キシレンオキシゲナーゼ遺伝子 |
| WO1996006172A1 (en) | 1994-08-23 | 1996-02-29 | Kirin Beer Kabushiki Kaisha | Keto group introducing enzyme, dna coding for the same, and process for producing ketocarotenoid |
| US5942426A (en) | 1994-11-18 | 1999-08-24 | Sumitomo Chemical Co., Ltd. | Human flavin-containing monooxygenase |
| JPH08140674A (ja) | 1994-11-18 | 1996-06-04 | Sumitomo Chem Co Ltd | ヒトフラビン含有モノオキシゲナーゼ |
| GB9510858D0 (en) | 1995-05-30 | 1995-07-26 | Chiroscience Ltd | Process for preparing lipoic acid |
| AU7072096A (en) * | 1995-09-25 | 1997-04-30 | Motorola, Inc. | Method and apparatus for relaying digitally signed messages |
| JPH09121864A (ja) | 1995-11-06 | 1997-05-13 | Cosmo Sogo Kenkyusho:Kk | ６−ヒドロキシニコチン酸モノオキシゲナーゼ遺伝子 |
| US5916791A (en) | 1995-11-24 | 1999-06-29 | Hirschberg; Joseph | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin |
| JPH1099078A (ja) | 1996-09-30 | 1998-04-21 | Kaiyo Bio Technol Kenkyusho:Kk | Ｒ−（−）−マンデル酸モノオキシゲナーゼ遺伝子 |
| FR2756845B1 (fr) | 1996-12-06 | 1999-02-26 | Genset Sa | Sequence nucleotidique codant pour une flavine monooxygenase , proteine correspondante et composition destinee au diagnostic et a la therapie du glaucome |
| WO1998038294A1 (en) | 1997-02-27 | 1998-09-03 | Union Camp Corporation | Growth-enhanced transgenic plants |
| ATE342361T1 (de) | 1997-04-15 | 2006-11-15 | Commw Scient Ind Res Org | Pflanzengene, die für fettsäurenepoxygenase kodieren und ihre verwendungen |
| EP1104459A1 (en) | 1998-08-12 | 2001-06-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
| US6864074B2 (en) | 1998-10-30 | 2005-03-08 | Canon Kabushiki Kaisha | Dna fragment carrying toluene monooxygenase gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
| EP1006191A3 (en) | 1998-12-03 | 2002-02-06 | Canon Kabushiki Kaisha | DNA encoding toluene monooxygenase, method for degrading chlorinated aliphatic hydrocarbons and aromatic compounds and method for environment remediation |
| MY126592A (en) | 1999-07-27 | 2006-10-31 | Basf Ag | Novel cytochrome p450 monooxygenases and their use for the oxidation of organic compounds |
| DE19935087A1 (de) | 1999-07-27 | 2001-02-08 | Inst Genomic Res Tigr Rockvill | DNA-Sequenzen, die Oxygenasen kodieren |
| AU6606500A (en) | 1999-08-06 | 2001-03-05 | G.D. Searle & Co. | Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) |
| AU776922B2 (en) | 1999-08-20 | 2004-09-23 | Danisco Usa Inc. | D-gluconolactone oxidase gene and method for producing recombinant D-gluconolactone oxidase |
| SE9903336D0 (sv) | 1999-09-17 | 1999-09-17 | Astacarotene Ab | DNA construct and its use |
| DE19951768A1 (de) | 1999-10-27 | 2001-05-03 | Basf Ag | Mikrobiologisches Verfahren zur Herstellung aromatischer Aldehyde und/oder Carbonsäuren |
| EP1106699A1 (en) | 1999-11-18 | 2001-06-13 | Eidgenössische Technische Hochschule Zürich | Biocatalytic epoxidation of vinylaromatic compounds |
| DE19957470A1 (de) | 1999-11-24 | 2001-06-21 | Actinodrug Pharmaceuticals Gmb | Tetrahydropyrimidin-Dioxygenase-Gen sowie Verfahren zur enzymatischen in vivo und in vitro Produktion von hydroxylierten Tetrahydropyrimidinen |
| CA2418155A1 (en) * | 2000-07-18 | 2002-01-24 | National Research Council Of Canada | Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
-
2001
- 2001-07-13 CA CA002418155A patent/CA2418155A1/en not_active Abandoned
- 2001-07-13 JP JP2002512345A patent/JP2004504025A/ja active Pending
- 2001-07-13 EP EP01953719A patent/EP1303614A2/en not_active Withdrawn
- 2001-07-13 WO PCT/CA2001/001032 patent/WO2002006452A2/en not_active Ceased
- 2001-07-13 AU AU2001276210A patent/AU2001276210A1/en not_active Abandoned
- 2001-07-13 US US10/312,585 patent/US7214520B2/en not_active Expired - Fee Related
-
2007
- 2007-03-28 US US11/727,730 patent/US7541168B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7214520B2 (en) | 2007-05-08 |
| US20070178558A1 (en) | 2007-08-02 |
| AU2001276210A1 (en) | 2002-01-30 |
| CA2418155A1 (en) | 2002-01-24 |
| US7541168B2 (en) | 2009-06-02 |
| US20050089846A1 (en) | 2005-04-28 |
| EP1303614A2 (en) | 2003-04-23 |
| WO2002006452A3 (en) | 2002-09-19 |
| WO2002006452A2 (en) | 2002-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7195898B2 (en) | Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium | |
| Chistoserdova et al. | Genetics of the serine cycle in Methylobacterium extorquens AM1: identification of sgaA and mtdA and sequences of sgaA, hprA, and mtdA | |
| JP4360786B2 (ja) | ラクトバシルスからのｎａｄｈオキシダーゼ | |
| JPH10229885A (ja) | 新規アルコールアルデヒド脱水素酵素 | |
| CN109852644B (zh) | 一种制备布瓦西坦中间体的方法 | |
| US7541168B2 (en) | Recombinant cyclopentanone monooxygenase [cpmo] | |
| JPWO2007094178A1 (ja) | 新規な（ｓ，ｓ）−ブタンジオール脱水素酵素、その遺伝子、及びその利用法 | |
| JP4133326B2 (ja) | 新規なフルクトシルアミノ酸オキシダーゼ | |
| JP2011067139A (ja) | 組換えベクター、形質転換体、及び２ｈ−ピラン−２−オン−４，６−ジカルボン酸の製造方法 | |
| JP4775258B2 (ja) | Ｌ−フクロースの製造方法およびｌ−フコースの製造方法 | |
| JP4216719B2 (ja) | ハロゲン化合物耐性新規ギ酸脱水素酵素及びその製造方法 | |
| WO2025123667A1 (zh) | 重组葡萄糖脱氢酶及其制备方法和应用 | |
| CN112410353A (zh) | 一种fkbS基因、含其的基因工程菌及其制备方法和用途 | |
| JP2002017351A (ja) | ホスホヘキシュロイソメラーゼ及びその遺伝子 | |
| JP2009247217A (ja) | 好気性組み換え微生物を用いる２−プロパノールの製造方法 | |
| JP5240970B2 (ja) | 界面活性剤存在下で安定なコレステロールオキシダーゼ | |
| EP0897984B1 (en) | D-Sorbitol dehydrogenase gene | |
| JPH11318438A (ja) | 組換え微生物３―ヒドロキシ酪酸デヒドロゲナ―ゼ、その製造方法およびその使用 | |
| CN100383236C (zh) | 葡萄糖脱氢酶的生产过程 | |
| JP4415247B2 (ja) | 新規なグリセロールキナーゼ、該遺伝子及び該遺伝子を用いたグリセロールキナーゼの製造法 | |
| JP2005528098A (ja) | マンニトール−２−デヒドロゲナーゼをコードするヌクレオチド配列並びにｄ−マンニトールの製造方法 | |
| JP2005102511A (ja) | 新規アルコール脱水素酵素、その遺伝子 | |
| JP2004041062A (ja) | 補酵素依存型を改変したギ酸脱水素酵素 | |
| JP3330670B2 (ja) | アルケンモノオキシゲナーゼ、これをコードする遺伝子及び形質転換微生物並びにアルケンのエポキシ化方法 | |
| WO2005123921A1 (ja) | 新規グリセロール脱水素酵素、その遺伝子、及びその利用法 |